Nvidia-backed AI drug developer Iambic is raising $150 million in U.S. IPO
- U.S. IPO: 7 events in the last 90 days
- Previous: 5 days earlier · City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs
What happened
The San Diego company's stock is expected to begin trading on Nasdaq Thursday under the ticker IAM, with the offering expected to close Friday
Summary assembled by rule from the sources below